Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Outcomes for clinical studies assessing drug and revascularization therapies for claudication and critical limb ischemia in peripheral artery disease.

Literature DB >> 23509032

Outcomes for clinical studies assessing drug and revascularization therapies for claudication and critical limb ischemia in peripheral artery disease.

Scott Kinlay¹.

Abstract

Entities: Disease

Mesh：

Year: 2013 PMID： 23509032 PMCID： PMC4507406 DOI： 10.1161/CIRCULATIONAHA.112.001232

Source DB: PubMed Journal: Circulation ISSN： 0009-7322 Impact factor: 29.690

× No keyword cloud information.

85 in total

1. Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials.

Authors: Judith G Regensteiner; John E Ware; Walter J McCarthy; Peter Zhang; William P Forbes; Jeffrey Heckman; William R Hiatt
Journal: J Am Geriatr Soc Date: 2002-12 Impact factor: 5.562

2. Progressive vs single-stage treadmill tests for evaluation of claudication.

Authors: A W Gardner; J S Skinner; B W Cantwell; L K Smith
Journal: Med Sci Sports Exerc Date: 1991-04 Impact factor: 5.411

3. Benefit of exercise conditioning for patients with peripheral arterial disease.

Authors: W R Hiatt; J G Regensteiner; M E Hargarten; E E Wolfel; E P Brass
Journal: Circulation Date: 1990-02 Impact factor: 29.690

4. Does postoperative surveillance with duplex scanning identify the failing distal bypass?

Authors: J G Robison; B M Elliott
Journal: Ann Vasc Surg Date: 1991-03 Impact factor: 1.466

5. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results.

Authors: Stephan H Duda; Benjamin Pusich; Goetz Richter; Peter Landwehr; Vincent L Oliva; Alexander Tielbeek; Benjamin Wiesinger; Jan Bart Hak; Hans Tielemans; Gerhard Ziemer; Ecatarina Cristea; Alexandra Lansky; Jean P Bérégi
Journal: Circulation Date: 2002-09-17 Impact factor: 29.690

6. The relationship between lower extremity functional strength and severity of peripheral arterial disease.

Authors: LeighAnn M Atkins; Andrew W Gardner
Journal: Angiology Date: 2004 Jul-Aug Impact factor: 3.619

7. Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes.

Authors: Philip S Mehler; Joseph R Coll; Raymond Estacio; Anne Esler; Robert W Schrier; William R Hiatt
Journal: Circulation Date: 2003-02-11 Impact factor: 29.690

8. Randomized trial of AT-1015 for treatment of intermittent claudication. A novel 5-hydroxytryptamine antagonist with no evidence of efficacy.

Authors: William R Hiatt; Alan T Hirsch; John P Cooke; Jeffrey W Olin; D Craig Brater; Mark A Creager
Journal: Vasc Med Date: 2004-02 Impact factor: 3.239

9. Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms.

Authors: Mary McGrae McDermott; Kiang Liu; Philip Greenland; Jack M Guralnik; Michael H Criqui; Cheeling Chan; William H Pearce; Joseph R Schneider; Luigi Ferrucci; Lillian Celic; Lloyd M Taylor; Ed Vonesh; Gary J Martin; Elizabeth Clark
Journal: JAMA Date: 2004-07-28 Impact factor: 56.272

10. Postoperative duplex scan surveillance of axillofemoral bypass grafts.

Authors: Scott E Musicant; Mary E Giswold; Christine J Olson; Gregory J Landry; Lloyd M Taylor; Richard A Yeager; James M Edwards; Gregory L Moneta
Journal: J Vasc Surg Date: 2003-01 Impact factor: 4.268

13 in total

1. Limb Perfusion During Exercise Assessed by Contrast Ultrasound Varies According to Symptom Severity in Patients with Peripheral Artery Disease.

Authors: Brian P Davidson; James Hodovan; O'Neil R Mason; Federico Moccetti; Avi Gupta; Matthew Muller; J Todd Belcik; Brian H Annex; Jonathan R Lindner
Journal: J Am Soc Echocardiogr Date: 2019-06-22 Impact factor: 5.251

2. Phase Ib Safety, Two-Dose Study of MultiGeneAngio in Patients with Chronic Critical Limb Ischemia.

Authors: Moshe Y Flugelman; Moshe Halak; Boris Yoffe; Jacob Schneiderman; Chen Rubinstein; Allan-Isaac Bloom; Eran Weinmann; Ilya Goldin; Victor Ginzburg; Olga Mayzler; Aaron Hoffman; Belly Koren; Diana Gershtein; Michal Inbar; Marina Hutoran; Adili Tsaba
Journal: Mol Ther Date: 2017-01-28 Impact factor: 11.454

Review 10. Leveraging Machine Learning and Artificial Intelligence to Improve Peripheral Artery Disease Detection, Treatment, and Outcomes.

Authors: Alyssa M Flores; Falen Demsas; Nicholas J Leeper; Elsie Gyang Ross
Journal: Circ Res Date: 2021-06-10 Impact factor: 23.213

Outcomes for clinical studies assessing drug and revascularization therapies for claudication and critical limb ischemia in peripheral artery disease.

1. Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials.

2. Progressive vs single-stage treadmill tests for evaluation of claudication.

3. Benefit of exercise conditioning for patients with peripheral arterial disease.

4. Does postoperative surveillance with duplex scanning identify the failing distal bypass?

5. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results.

6. The relationship between lower extremity functional strength and severity of peripheral arterial disease.

7. Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes.

8. Randomized trial of AT-1015 for treatment of intermittent claudication. A novel 5-hydroxytryptamine antagonist with no evidence of efficacy.

9. Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms.

10. Postoperative duplex scan surveillance of axillofemoral bypass grafts.

1. Limb Perfusion During Exercise Assessed by Contrast Ultrasound Varies According to Symptom Severity in Patients with Peripheral Artery Disease.

2. Phase Ib Safety, Two-Dose Study of MultiGeneAngio in Patients with Chronic Critical Limb Ischemia.

Review 3. Endovascular intervention for peripheral artery disease.

4. Prospects for multimodality imaging in peripheral artery disease.

Review 5. The current state of stem cell therapy for peripheral artery disease.

6. Management of Critical Limb Ischemia.

7. Therapy for peripheral artery disease: gaps in treating patients with claudication.

8. Association of Blood Pressure Measurements With Peripheral Artery Disease Events.

Review 9. Physiology in medicine: peripheral arterial disease.

Review 10. Leveraging Machine Learning and Artificial Intelligence to Improve Peripheral Artery Disease Detection, Treatment, and Outcomes.